Mulch Manufacturing Inc. v. Advanced Polymer Solutions, LLC
947 F. Supp. 2d 841
S.D. Ohio2013Background
- MMI, an Ohio mulch manufacturer, contracted APS (New York) for fire-retardant development under an R&D Agreement; the project had three phases with escalating payments by MMI.
- The July 2006 R&D Agreement required APS to develop formulations per MMI’s specifications and to provide samples for testing; Phase 1 lasted four weeks, Phase 2 four weeks, with an optional Phase 3 for final tuning and patent transfer.
- MMI paid $30,000 for Phase 1 and $50,000 for Phase 2; the agreement contemplated possible ongoing manufacturing but did not obligate APS to do so.
- From Oct 2006 to May 2010, MMI purchased FR-48 from APS, which was manufactured by Spartan, not a formulation APS developed for MMI; MSDS and communications referenced Formulation 48, not Spartan FR-48.
- MMI later discovered APS sold FR-48 as the product to MMI and began producing its own flame-retardant; APS and Ryan allegedly misrepresented the product’s origin and formulation.
- MMI asserted multiple theories—fraud, ODTPA, breach of contract, fiduciary duty, and negligent misrepresentation—leading to this cross-motions for summary judgment.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether Ohio or New York law applies to the action | MMI: Ohio law governs tort and contract aspects; broader ties to Ohio. | APS/ Ryan: New York law largely similar; ODTPA implications less under Ohio law. | Ohio law applies to ODTPA claims; overall, no conflict necessitates foreign-law application; other claims governed by Ohio law. |
| Whether the R&D Agreement’s breach is factually supportable | MMI claims APS failed to deliver formulations meeting its specifications. | APS says initial phases complied; no guarantee of ultimate success. | Fact question remains; partial integration plus ambiguity allows reasonable jury to find breach of the R&D Agreement. |
| Whether the purchase orders were for formulation 48 or FR-48 | MMI relied on APS to provide a formulation (Formulation 48). | Purchase orders were ambiguous; FR-48 may have been intended. | Genuine dispute on contractual intent; summary judgment inappropriate on whether orders covered Formulation 48 or FR-48. |
| Whether MMI can prove fraud and related ODTPA claims | APS/ Ryan misrepresented product origin and formulation to induce purchases. | Representations were ambiguous or imprecise; product identified as Spartan FR-48; no clear intent to deceive. | Issues of material fact remain; fraud and ODTPA claims survive for trial. |
| Whether Ryan can be personally liable for torts | Ryan participated in misrepresentations; should be individually liable. | Ryan acted within corporate role; not a party to contract. | Ryan may be held individually liable for fraud, negligent misrepresentation, and ODTPA; breach-of-contract claims barred. |
Key Cases Cited
- Celotex Corp. v. Catrett, 477 U.S. 317 (1986) (burden-shifting framework for summary judgment)
- Anderson v. Liberty Lobby, Inc., 477 U.S. 242 (1986) (genuine issue of material fact must be shown to defeat summary judgment)
- Westfield Ins. Co. v. Galatis, 100 Ohio St.3d 216, 797 N.E.2d 1256 (Ohio 2003) (extrinsic evidence may illuminate contract interpretation when ambiguous)
- In re Nat’l Century Fin. Enter., Inv. Litig., 905 F. Supp. 2d 814 (S.D. Ohio 2012) ( torts in settlement context; conflict of choice-of-law considerations in complex actions)
- MedChoice Fin., LLC v. ADS Alliance Data Sys., Inc., 857 F. Supp. 2d 665 (S.D. Ohio 2012) (economic loss rule and fraud/ODTPA interplay in commercial transactions)